Kaival Brands Provides Business Update in Letter to Shareholders
Operating Expenses decreased to $13.2 million compared to $15.6 million, with the decrease driven primarily by disciplined cost management.
- Operating Expenses decreased to $13.2 million compared to $15.6 million, with the decrease driven primarily by disciplined cost management.
- As of October 31, 2023, Kaival Brands had working capital of approximately $1.9 million and total cash of approximately $0.5 million.
- Through it all, we remain committed to steadfast compliance with established FDA requirements for our products and business as we have since our inception.
- Those ten products remain available for sale through Kaival Brands, subject to FDA’s enforcement discretion.